Earlier, we cited a report from the New York Post quoting President Trump as saying a U.S. delegation had just departed for Islamabad for the next round of talks with Iran. Now, CNN is reporting that ...

Small-cap and midcap stocks were outperforming on Monday, rising while indexes like the S&P 500 moved lower. Small caps have handily outperformed their larger peers in 2026, having bounced back from a ...

U.S. stocks opened lower on Monday, although losses remained relatively muted, as escalating tensions between the U.S. and Iran over the weekend sent crude-oil prices higher once again. The S&P 500 ...

After another sizable drop after futures trading opened Sunday evening, major U.S. equity indexes have fought their way back to nearly unchanged on the day. The small-cap Russell 2000 and mid-cap S&P ...

U.S. stocks have pared most of their losses from overnight, with the Dow Jones Industrial Average back to unchanged on the day, as the latest headlines helped to ease investors' anxieties. The New ...

NEW YORK CITY, NY / ACCESS Newswire / April 19, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against NuScale Power Corporation ("NuScale" or the "Company") (NYSE:SMR).

Eli Lilly has agreed to buy privately held cancer biotech Kelonia Therapeutics for up to $7 billion in cash in a deal that bolsters the drugmaker's genetic-medicine capabilities. Eli Lilly on Monday ...

Partnership outlines short-term integration for intuitive "spatial interaction" and long-term commercial models for enterprise AR solutions, with demos planned for the AWE 2026. Yokneam Illit, Israel, ...

Jersey Mike's Subs, the sandwich chain majority owned by private-equity giant Blackstone, is going public. Jersey Mike's on Monday said it has confidentially submitted a draft registration statement ...

Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence BioMed" or the "Company"), a clinical-stage biopharmaceutical company advancing nature-derived psychedelic therapies and manufacturing ...

Arcus Biosciences is discontinuing a phase 3 lung cancer trial it was conducting with Gilead Sciences. Arcus, an oncology company, said Monday it was ending the trial due to futility, meaning it doesn ...

Genius Group Limited (NYSE American: GNS) ("Genius Group" or the "Company"), a leading AI-powered education group, today announced that it has received the final award from the ICC Arbitration ...